| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Lenalidomide | FAERS: 116 Canada Vigilance: 3 | Canada Vigilance OFFSIDES US FAERS | |
| 2 | Azacitidine | FAERS: 85 Canada Vigilance: 4 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 3 | Deferasirox | FAERS: 73 Canada Vigilance: 4 | Canada Vigilance OFFSIDES US FAERS | |
| 4 | eltrombopag | FAERS: 5 | US FAERS | |
| 5 | Thalidomide | FAERS: 3 | US FAERS | |
| 6 | Cyclophosphamide | FAERS: 2 | US FAERS | |
| 7 | Hydroxyurea | FAERS: 2 | OFFSIDES US FAERS | |
| 8 | Decitabine | FAERS: 1 | US FAERS | |
| 9 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 10 | Paclitaxel | FAERS: 1 | US FAERS | |
| 11 | Busulfan | OFFSIDES | ||
| 12 | Clofarabine | OFFSIDES | ||
| 13 | Digoxin | OFFSIDES | ||
| 14 | Estrogens, Conjugated (USP) | OFFSIDES | ||
| 15 | Selenium | OFFSIDES | ||
| 16 | Sotalol | OFFSIDES | ||
| 17 | Temozolomide | OFFSIDES | ||
| 18 | fludarabine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.